By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

The Carbon Cure: How Low-Temperature Carburizing Tames Friction in 3D-Printed Steel of Engineering today

A new study shows that blocking the IL-1β signaling pathway in the brain can halt the damaging inflammation that drives neuromyelitis optica (NMO), a severe autoimmune disease. Researchers found that using an antisense oligonucleotide (ASO) to lower IL-1β levels protected nerve cells and improved movement in mice, offering a promising new treatment approach for this condition.

Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Infectious Diseases - A historical lens on pandemic preparedness: lessons from Uganda’s viral research institute

Infectious Diseases

A historical lens on pandemic preparedness: lessons from Uganda’s viral research institute

Last updated: March 19, 2026 2:10 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

A historical lens on pandemic preparedness: lessons from Uganda’s viral research institute

A perspective piece in The Lancet examines the history of the Uganda Virus Research Institute (UVRI) to draw critical parallels for today’s global health landscape. The article highlights a pivotal moment in the 1960s when the decolonization of Africa forced a complete restructuring of international health research institutions and partnerships. This historical case study is presented as a vital lesson for contemporary researchers and policymakers who are navigating a new “tectonic shift” in global health, characterized by significant reductions in funding and development assistance from major high-income countries. The analysis underscores the challenges and opportunities of rebuilding equitable and productive international research networks during periods of profound geopolitical and financial transition, directly relevant to current efforts in outbreak surveillance and pandemic preparedness.

Study Significance: For professionals focused on infectious diseases and global health security, this historical analysis provides a crucial framework for strategic planning. It emphasizes that sustainable outbreak surveillance and a robust One Health approach cannot rely solely on transient international funding but must be built on resilient, equitable institutional foundations. Understanding these historical cycles of support and dismantlement is essential for designing pandemic preparedness strategies that can withstand political and financial volatility.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Key Highlights
Next Article A new brain signature for schizophrenia risk refines pharmacogenomics and drug targeting
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Critical Gap in Adolescent HIV Prevention

Acknowledging the Gatekeepers of Infectious Disease Research

Retail milk emerges as a sentinel for tracking H5N1 in dairy herds

The Hidden Epidemic: Normal-Weight Central Obesity in Mongolia

A Nano-Antioxidant’s Dual Assault on Inflammatory Bowel Disease

Data Sovereignty Clashes Stall US Global Health Partnerships in Africa

A New Frontier in Host-Pathogen Warfare: The Early Signs of Synapse Dismantling

A shot against decline: Shingles vaccine linked to lower dementia risk

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Energy
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?